[Form 4] Cintas Corp Insider Trading Activity
Jim Rozakis, Executive Vice President & COO of Cintas Corporation (CTAS), reported multiple equity transactions dated 08/11/2025. The filing shows a grant of 6,852 restricted shares under the company’s equity compensation plan and several stock option awards totaling 69,302 options across five strike prices.
The option awards listed include 23,326 options at $223.88 (expiration 08/11/2035), 16,900 at $97.22 (07/27/2031), 13,884 at $99.46 (07/26/2032), 6,920 at $61.99 (05/29/2030) and 8,272 at $73.39 (07/26/2030). The filing also records several dispositions of common stock (amounts reported: 11,545, 9,563, 4,118, 5,158). Post-transaction beneficial ownership figures in the filing range from 259,521 to 280,271 shares, with 2,784 shares held indirectly via a 401(k) plan.
The accompanying disclosure explains the restricted shares were granted under the Equity Compensation Plan and the options vest in thirds on the third, fourth and fifth anniversaries of the grant date.
Jim Rozakis, Vicepresidente esecutivo e COO di Cintas Corporation (CTAS), ha comunicato più operazioni su partecipazioni azionarie datate 08/11/2025. La segnalazione indica la concessione di 6,852 azioni vincolate nell'ambito del piano di compensazione azionaria della società e diversi premi di opzioni su azioni per un totale di 69,302 opzioni distribuite su cinque prezzi di esercizio.
Le opzioni elencate comprendono 23,326 opzioni a $223.88 (scadenza 08/11/2035), 16,900 a $97.22 (07/27/2031), 13,884 a $99.46 (07/26/2032), 6,920 a $61.99 (05/29/2030) e 8,272 a $73.39 (07/26/2030). La comunicazione registra inoltre diverse cessioni di azioni ordinarie (importi riportati: 11,545, 9,563, 4,118, 5,158). Dopo le operazioni, la titolarità beneficiaria indicata varia tra 259,521 e 280,271 azioni, con 2,784 azioni detenute indirettamente tramite un piano 401(k).
La nota allegata precisa che le azioni vincolate sono state assegnate ai sensi dell’Equity Compensation Plan e che le opzioni maturano per un terzo al terzo, quarto e quinto anniversario della data di assegnazione.
Jim Rozakis, vicepresidente ejecutivo y COO de Cintas Corporation (CTAS), informó varias operaciones sobre acciones fechadas el 08/11/2025. El informe muestra la concesión de 6,852 acciones restringidas en el marco del plan de compensación en acciones de la compañía y varios premios de opciones por un total de 69,302 opciones repartidas en cinco precios de ejercicio.
Las opciones detalladas incluyen 23,326 opciones a $223.88 (vencimiento 08/11/2035), 16,900 a $97.22 (07/27/2031), 13,884 a $99.46 (07/26/2032), 6,920 a $61.99 (05/29/2030) y 8,272 a $73.39 (07/26/2030). El informe también registra varias cesiones de acciones ordinarias (montos declarados: 11,545, 9,563, 4,118, 5,158). Tras las transacciones, la titularidad beneficiaria consignada oscila entre 259,521 y 280,271 acciones, con 2,784 acciones mantenidas de forma indirecta a través de un plan 401(k).
La divulgación adjunta explica que las acciones restringidas se otorgaron bajo el Equity Compensation Plan y que las opciones se consolidan en tercios en el tercer, cuarto y quinto aniversario de la fecha de concesión.
Jim Rozakis는 Cintas Corporation(CTAS)의 전무 겸 최고운영책임자로서 08/11/2025자 다수의 주식 거래를 보고했습니다. 신고서에는 회사의 주식 보상 계획에 따라 6,852주의 제한 주식이 부여되었고, 총 69,302개의 옵션이 다섯 개 행사가격으로 수여되었다고 기재되어 있습니다.
보고된 옵션 내역은 $223.88에 23,326개 (만기 08/11/2035), $97.22에 16,900개 (07/27/2031), $99.46에 13,884개 (07/26/2032), $61.99에 6,920개 (05/29/2030), $73.39에 8,272개 (07/26/2030)를 포함합니다. 또한 보통주 처분 건도 여러 건 기록되어 있으며(보고된 수량: 11,545, 9,563, 4,118, 5,158), 거래 후 실질 보유 주식 수는 259,521에서 280,271주 사이로 보고되었고 2,784주는 401(k) 플랜을 통해 간접 보유되어 있습니다.
첨부된 공시에는 제한 주식이 주식 보상 계획에 따라 부여되었으며, 옵션은 부여일로부터 3, 4, 5주년마다 각각 1/3씩 베스팅된다고 설명되어 있습니다.
Jim Rozakis, vice-président exécutif et COO de Cintas Corporation (CTAS), a déclaré plusieurs opérations sur titres datées du 08/11/2025. Le dépôt indique l’octroi de 6,852 actions restreintes dans le cadre du plan de rémunération en actions de la société ainsi que plusieurs attributions d’options représentant au total 69,302 options réparties sur cinq prix d’exercice.
Les attributions d’options comprennent notamment 23,326 options à $223.88 (expiration 08/11/2035), 16,900 à $97.22 (07/27/2031), 13,884 à $99.46 (07/26/2032), 6,920 à $61.99 (05/29/2030) et 8,272 à $73.39 (07/26/2030). Le dossier enregistre également plusieurs cessions d’actions ordinaires (montants déclarés : 11,545, 9,563, 4,118, 5,158). Après ces opérations, la détention effective déclarée varie entre 259,521 et 280,271 actions, dont 2,784 détenues indirectement via un plan 401(k).
La notice précise que les actions restreintes ont été attribuées en vertu du Equity Compensation Plan et que les options deviennent acquises par tranches d’un tiers au 3e, 4e et 5e anniversaire de la date d’attribution.
Jim Rozakis, Executive Vice President & COO der Cintas Corporation (CTAS), meldete mehrere Aktiengeschäfte mit Datum 08/11/2025. Die Meldung weist die Gewährung von 6,852 eingeschränkten Aktien im Rahmen des Aktienvergütungsplans des Unternehmens sowie mehrere Aktienoptionszuteilungen in Höhe von insgesamt 69,302 Optionen auf, verteilt auf fünf Ausübungspreise, aus.
Die aufgeführten Optionszuteilungen umfassen 23,326 Optionen zu $223.88 (Laufzeit bis 08/11/2035), 16,900 zu $97.22 (07/27/2031), 13,884 zu $99.46 (07/26/2032), 6,920 zu $61.99 (05/29/2030) und 8,272 zu $73.39 (07/26/2030). Die Meldung erfasst ferner mehrere Veräußerungen von Stammaktien (gemeldete Beträge: 11,545, 9,563, 4,118, 5,158). Nach den Transaktionen liegen die Angaben zum wirtschaftlichen Eigentum zwischen 259,521 und 280,271 Aktien, wobei 2,784 Aktien indirekt über einen 401(k)-Plan gehalten werden.
Die beigefügte Offenlegung erklärt, dass die eingeschränkten Aktien im Rahmen des Equity Compensation Plan gewährt wurden und die Optionen zu jeweils einem Drittel am dritten, vierten und fünften Jahrestag der Gewährung unverfallbar werden.
- 6,852 restricted shares granted under the Cintas Equity Compensation Plan
- 69,302 stock options awarded across five strike prices, supporting multi-year executive alignment
- Explicit vesting schedule: one-third on the third, fourth and fifth anniversaries
- Multiple share dispositions reported (11,545; 9,563; 4,118; 5,158) without explanation in the filing
- Post-transaction beneficial ownership varies across reported lines (range 259,521 to 280,271), creating multiple snapshot figures rather than a single consolidated ownership total
Insights
TL;DR: Routine executive equity awards and several share dispositions were reported; no operational or balance-sheet changes disclosed.
The Form 4 discloses compensation-related equity activity for CTAS leadership rather than corporate events. Total option awards equal 69,302 options across five exercise prices, and 6,852 restricted shares were granted. Several share dispositions are reported in discrete amounts. These items affect executive ownership and potential future dilution from option exercise, but the filing contains no information about company performance or material corporate developments.
TL;DR: Grants use multi-year vesting and a 10-year option term for at least one award; the filing documents awards and dispositions without stated rationale.
The awards include standard equity instruments: restricted shares under the Equity Compensation Plan and multiple stock option grants with explicit exercise prices and expiration/ exercisability dates. The vesting schedule—one-third on the third, fourth and fifth anniversaries—ties value realization to multi-year retention. The filing lists specific disposition amounts but provides no explanation for those sales or transfers.
Jim Rozakis, Vicepresidente esecutivo e COO di Cintas Corporation (CTAS), ha comunicato più operazioni su partecipazioni azionarie datate 08/11/2025. La segnalazione indica la concessione di 6,852 azioni vincolate nell'ambito del piano di compensazione azionaria della società e diversi premi di opzioni su azioni per un totale di 69,302 opzioni distribuite su cinque prezzi di esercizio.
Le opzioni elencate comprendono 23,326 opzioni a $223.88 (scadenza 08/11/2035), 16,900 a $97.22 (07/27/2031), 13,884 a $99.46 (07/26/2032), 6,920 a $61.99 (05/29/2030) e 8,272 a $73.39 (07/26/2030). La comunicazione registra inoltre diverse cessioni di azioni ordinarie (importi riportati: 11,545, 9,563, 4,118, 5,158). Dopo le operazioni, la titolarità beneficiaria indicata varia tra 259,521 e 280,271 azioni, con 2,784 azioni detenute indirettamente tramite un piano 401(k).
La nota allegata precisa che le azioni vincolate sono state assegnate ai sensi dell’Equity Compensation Plan e che le opzioni maturano per un terzo al terzo, quarto e quinto anniversario della data di assegnazione.
Jim Rozakis, vicepresidente ejecutivo y COO de Cintas Corporation (CTAS), informó varias operaciones sobre acciones fechadas el 08/11/2025. El informe muestra la concesión de 6,852 acciones restringidas en el marco del plan de compensación en acciones de la compañía y varios premios de opciones por un total de 69,302 opciones repartidas en cinco precios de ejercicio.
Las opciones detalladas incluyen 23,326 opciones a $223.88 (vencimiento 08/11/2035), 16,900 a $97.22 (07/27/2031), 13,884 a $99.46 (07/26/2032), 6,920 a $61.99 (05/29/2030) y 8,272 a $73.39 (07/26/2030). El informe también registra varias cesiones de acciones ordinarias (montos declarados: 11,545, 9,563, 4,118, 5,158). Tras las transacciones, la titularidad beneficiaria consignada oscila entre 259,521 y 280,271 acciones, con 2,784 acciones mantenidas de forma indirecta a través de un plan 401(k).
La divulgación adjunta explica que las acciones restringidas se otorgaron bajo el Equity Compensation Plan y que las opciones se consolidan en tercios en el tercer, cuarto y quinto aniversario de la fecha de concesión.
Jim Rozakis는 Cintas Corporation(CTAS)의 전무 겸 최고운영책임자로서 08/11/2025자 다수의 주식 거래를 보고했습니다. 신고서에는 회사의 주식 보상 계획에 따라 6,852주의 제한 주식이 부여되었고, 총 69,302개의 옵션이 다섯 개 행사가격으로 수여되었다고 기재되어 있습니다.
보고된 옵션 내역은 $223.88에 23,326개 (만기 08/11/2035), $97.22에 16,900개 (07/27/2031), $99.46에 13,884개 (07/26/2032), $61.99에 6,920개 (05/29/2030), $73.39에 8,272개 (07/26/2030)를 포함합니다. 또한 보통주 처분 건도 여러 건 기록되어 있으며(보고된 수량: 11,545, 9,563, 4,118, 5,158), 거래 후 실질 보유 주식 수는 259,521에서 280,271주 사이로 보고되었고 2,784주는 401(k) 플랜을 통해 간접 보유되어 있습니다.
첨부된 공시에는 제한 주식이 주식 보상 계획에 따라 부여되었으며, 옵션은 부여일로부터 3, 4, 5주년마다 각각 1/3씩 베스팅된다고 설명되어 있습니다.
Jim Rozakis, vice-président exécutif et COO de Cintas Corporation (CTAS), a déclaré plusieurs opérations sur titres datées du 08/11/2025. Le dépôt indique l’octroi de 6,852 actions restreintes dans le cadre du plan de rémunération en actions de la société ainsi que plusieurs attributions d’options représentant au total 69,302 options réparties sur cinq prix d’exercice.
Les attributions d’options comprennent notamment 23,326 options à $223.88 (expiration 08/11/2035), 16,900 à $97.22 (07/27/2031), 13,884 à $99.46 (07/26/2032), 6,920 à $61.99 (05/29/2030) et 8,272 à $73.39 (07/26/2030). Le dossier enregistre également plusieurs cessions d’actions ordinaires (montants déclarés : 11,545, 9,563, 4,118, 5,158). Après ces opérations, la détention effective déclarée varie entre 259,521 et 280,271 actions, dont 2,784 détenues indirectement via un plan 401(k).
La notice précise que les actions restreintes ont été attribuées en vertu du Equity Compensation Plan et que les options deviennent acquises par tranches d’un tiers au 3e, 4e et 5e anniversaire de la date d’attribution.
Jim Rozakis, Executive Vice President & COO der Cintas Corporation (CTAS), meldete mehrere Aktiengeschäfte mit Datum 08/11/2025. Die Meldung weist die Gewährung von 6,852 eingeschränkten Aktien im Rahmen des Aktienvergütungsplans des Unternehmens sowie mehrere Aktienoptionszuteilungen in Höhe von insgesamt 69,302 Optionen auf, verteilt auf fünf Ausübungspreise, aus.
Die aufgeführten Optionszuteilungen umfassen 23,326 Optionen zu $223.88 (Laufzeit bis 08/11/2035), 16,900 zu $97.22 (07/27/2031), 13,884 zu $99.46 (07/26/2032), 6,920 zu $61.99 (05/29/2030) und 8,272 zu $73.39 (07/26/2030). Die Meldung erfasst ferner mehrere Veräußerungen von Stammaktien (gemeldete Beträge: 11,545, 9,563, 4,118, 5,158). Nach den Transaktionen liegen die Angaben zum wirtschaftlichen Eigentum zwischen 259,521 und 280,271 Aktien, wobei 2,784 Aktien indirekt über einen 401(k)-Plan gehalten werden.
Die beigefügte Offenlegung erklärt, dass die eingeschränkten Aktien im Rahmen des Equity Compensation Plan gewährt wurden und die Optionen zu jeweils einem Drittel am dritten, vierten und fünften Jahrestag der Gewährung unverfallbar werden.
FAQ
What transactions did Jim Rozakis report on 08/11/2025 for CTAS?
How many stock options were granted to Jim Rozakis and at what exercise prices?
What is the vesting schedule for the awarded options?
How many shares does Rozakis beneficially own after the reported transactions?
Does the Form 4 explain reasons for the share dispositions?
